Home/Filings/4/0001213900-18-007754
4//SEC Filing

O'Loughlin Steve 4

Accession 0001213900-18-007754

CIK 0001388320other

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 6:08 PM ET

Size

4.6 KB

Accession

0001213900-18-007754

Insider Transaction Report

Form 4
Period: 2018-06-15
O'Loughlin Steve
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2018-06-15$0.50/sh+12,000$6,00025,500 total

Issuer

Actinium Pharmaceuticals, Inc.

CIK 0001388320

Entity typeother

Related Parties

1
  • filerCIK 0001615840

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 6:08 PM ET
Size
4.6 KB